株探米国株
英語
エドガーで原本を確認する
0001388658false00013886582023-05-242023-05-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 8-K 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 24, 2023
iRhythm Technologies, Inc. 
(Exact name of Registrant as specified in its charter) 
Delaware 001-37918 20-8149544
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification Number)
699 8th Street, Suite 600 
San Francisco, California 94103 
(Address of principal executive office) (Zip Code)
(415) 632-5700 
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share IRTC The NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐ 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 









Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 24, 2023, the Company held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). Present at the Annual Meeting in person or by proxy were holders of 29,240,639 shares of the Company’s common stock, representing approximately 96.0% of the shares of the Company’s common stock entitled to vote as of March 30, 2023, the record date for the Annual Meeting, and constituting a quorum for the transaction of business. The matters before the Annual Meeting are described in more detail in the Company’s definitive proxy statement filed with the United States Securities and Exchange Commission on April 12, 2023.
Proposal 1 – Election of Directors. The following nominees were elected as directors to serve until the 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified:

Nominee Votes For Votes Withheld Broker Non-Votes
Cathleen Noel Bairey Merz, M.D. 27,044,146 726,219 1,470,274
Quentin S. Blackford 26,735,810 1,034,555 1,470,274
Bruce G. Bodaken 19,685,233 8,085,132 1,470,274
Karen Ling 27,364,418 405,947 1,470,274
Mark J. Rubash 27,122,720 647,645 1,470,274
Ralph Snyderman, M.D. 26,841,665 928,700 1,470,274
Abhijit Y. Talwalkar 24,563,707 3,206,658 1,470,274

Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm. The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2023 was ratified.

Votes For Votes Against Abstentions Broker Non-Votes
29,174,545 54,976 11,118

Proposal 3 - Advisory vote to approve Named Executive Officer Compensation. The stockholders voted for, on a non-binding advisory basis, the approval of named executive officer compensation. The following sets forth the results of the voting with respect to this proposal:

Votes For Votes Against Abstentions Broker Non-Votes
24,771,355 2,982,847 16,163 1,470,274



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
IRHYTHM TECHNOLOGIES, INC.
Date: May 25, 2023
By: /s/ Quentin S. Blackford
Quentin S. Blackford
Chief Executive Officer